Nothing
README.md
In polypharmacy: Calculate Several Polypharmacy Indicators
polypharmacy 
This package analyse prescription drugs deliveries to calculate several
indicators of polypharmacy corresponding to the various definitions
found in the literature.
It is essential to know the concepts used to calculate the various
polypharmacy indicators to adequately use this package.
The core of the package is the data_process() function that creates
the data.table of pharmacists drug deliveries by restructuring the
drug delivery records (usually extracted from a pharmacy or a health
insurance information system) into continuous periods of drug
availability, applying user-defined arguments such as the grace periods
between renewals or the longest treatment duration that an individual
may accumulate through the successive renewals.
Then, each polypharmacy indicator can be computed using the
corresponding function (ind_simult(), ind_stdcumul(),
ind_wcumul(), ind_stdcontinuous(), ind_ucontinuous()) or using the
overall function indicators() and select all the desired indicator(s)
to be calculated at once.
Prior to running data_process() the user may need to pre-process the
table of original drug delivery records to break down combination drug
into their individual components (drugs_bkdn()) and/or to overwrite
the treatment duration of specified drugs with constant time periods
(cst_trt_dur()).
Installation
install.packages("polypharmacy")
Development version
To get a bug fix or to use a feature from the development version, you
can install the development version of polypharamcy from GitHub.
# install.packages("remotes")
remotes::install_github("guiboucher/polypharmacy")
References
- Bjerrum, L., Rosholm, J. U., Hallas, J., & Kragstrup, J. (1997).
Methods for estimating the occurrence of polypharmacy by means of a
prescription database. [journal article]. European Journal of
Clinical Pharmacology, 53(1), 7-11. DOI:
10.1007/s002280050329
- Chan, D.-C., Hao, Y.-T., & Wu, S.-C. (2009a). Characteristics of
outpatient prescriptions for frail Taiwanese elders with long-term
care needs. Pharmacoepidemiology and Drug Safety, 18(4), 327-334.
DOI:
10.1002/pds.1712
- Fincke, B. G., Snyder, K., Cantillon, C., Gaehde, S., Standring, P.,
Fiore, L., . . . Gagnon, D. R. (2005). Three complementary
definitions of polypharmacy: methods, application and comparison of
findings in a large prescription database. Pharmacoepidemiol Drug
Saf, 14(2), 121-128. DOI:
10.1002/pds.966
- Hovstadius, B., Astrand, B., & Petersson, G. (2009). Dispensed drugs
and multiple medications in the Swedish population: an
individual-based register study.(Technical advance)(Report). BMC
Clinical Pharmacology, 9(11), 11. DOI:
10.1186/1472-6904-9-11
- Hovstadius, B., Astrand, B., & Petersson, G. (2010). Assessment of
regional variation in polypharmacy. Pharmacoepidemiology and Drug
Safety, 19(4), 375-383. DOI:
10.1002/pds.1921
- Kennerfalk, A., Ruigómez, A., Wallander, M.-A., Wilhelmsen, L., &
Johansson, S. (2002). Geriatric Drug Therapy and Healthcare
Utilization in the United Kingdom. Annals of Pharmacotherapy, 36(5),
797-803. DOI:
10.1345/aph.1A226
- Masnoon, N., Shakib, S., Kalisch-Ellett, L., & Caughey, G. E.
(2017). What is polypharmacy? A systematic review of definitions.
BMC Geriatr, 17(1), 230. DOI:
10.1186/s12877-017-0621-2
- Narayan, S. W., & Nishtala, P. S. (2015). Associations of
Potentially Inappropriate Medicine Use with Fall-Related
Hospitalisations and Primary Care Visits in Older New Zealanders: A
Population-Level Study Using the Updated 2012 Beers Criteria.
[journal article]. Drugs - Real World Outcomes, 2(2), 137-141.
DOI:
10.1007/s40801-015-0020-y
- Nishtala, P. S., & Salahudeen, M. S. (2015). Temporal Trends in
Polypharmacy and Hyperpolypharmacy in Older New Zealanders over a
9-Year Period: 2005-2013. Gerontology, 61(3), 195-202. DOI:
10.1159/000368191
- Park, H. Y., Ryu, H. N., Shim, M. K., Sohn, H. S., & Kwon, J. W.
(2016). Prescribed drugs and polypharmacy in healthcare service
users in South Korea: an analysis based on National Health Insurance
Claims data. Int J Clin Pharmacol Ther, 54(5), 369-377. DOI:
10.5414/cp202484
- Veehof, L., Stewart, R., Haaijer-Ruskamp, F., & Jong, B. M. (2000).
The development of polypharmacy. A longitudinal study. Fam Pract,
17(3), 261-267. DOI:
10.1093/fampra/17.3.261
Try the polypharmacy package in your browser
Any scripts or data that you put into this service are public.
polypharmacy documentation built on July 12, 2021, 5:08 p.m.
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
polypharmacy
This package analyse prescription drugs deliveries to calculate several indicators of polypharmacy corresponding to the various definitions found in the literature.
It is essential to know the concepts used to calculate the various
polypharmacy indicators to adequately use this package.
The core of the package is the data_process() function that creates
the data.table of pharmacists drug deliveries by restructuring the
drug delivery records (usually extracted from a pharmacy or a health
insurance information system) into continuous periods of drug
availability, applying user-defined arguments such as the grace periods
between renewals or the longest treatment duration that an individual
may accumulate through the successive renewals.
Then, each polypharmacy indicator can be computed using the
corresponding function (ind_simult(), ind_stdcumul(),
ind_wcumul(), ind_stdcontinuous(), ind_ucontinuous()) or using the
overall function indicators() and select all the desired indicator(s)
to be calculated at once.
Prior to running data_process() the user may need to pre-process the
table of original drug delivery records to break down combination drug
into their individual components (drugs_bkdn()) and/or to overwrite
the treatment duration of specified drugs with constant time periods
(cst_trt_dur()).
Installation
install.packages("polypharmacy")
Development version
To get a bug fix or to use a feature from the development version, you
can install the development version of polypharamcy from GitHub.
# install.packages("remotes")
remotes::install_github("guiboucher/polypharmacy")
References
- Bjerrum, L., Rosholm, J. U., Hallas, J., & Kragstrup, J. (1997). Methods for estimating the occurrence of polypharmacy by means of a prescription database. [journal article]. European Journal of Clinical Pharmacology, 53(1), 7-11. DOI: 10.1007/s002280050329
- Chan, D.-C., Hao, Y.-T., & Wu, S.-C. (2009a). Characteristics of outpatient prescriptions for frail Taiwanese elders with long-term care needs. Pharmacoepidemiology and Drug Safety, 18(4), 327-334. DOI: 10.1002/pds.1712
- Fincke, B. G., Snyder, K., Cantillon, C., Gaehde, S., Standring, P., Fiore, L., . . . Gagnon, D. R. (2005). Three complementary definitions of polypharmacy: methods, application and comparison of findings in a large prescription database. Pharmacoepidemiol Drug Saf, 14(2), 121-128. DOI: 10.1002/pds.966
- Hovstadius, B., Astrand, B., & Petersson, G. (2009). Dispensed drugs and multiple medications in the Swedish population: an individual-based register study.(Technical advance)(Report). BMC Clinical Pharmacology, 9(11), 11. DOI: 10.1186/1472-6904-9-11
- Hovstadius, B., Astrand, B., & Petersson, G. (2010). Assessment of regional variation in polypharmacy. Pharmacoepidemiology and Drug Safety, 19(4), 375-383. DOI: 10.1002/pds.1921
- Kennerfalk, A., Ruigómez, A., Wallander, M.-A., Wilhelmsen, L., & Johansson, S. (2002). Geriatric Drug Therapy and Healthcare Utilization in the United Kingdom. Annals of Pharmacotherapy, 36(5), 797-803. DOI: 10.1345/aph.1A226
- Masnoon, N., Shakib, S., Kalisch-Ellett, L., & Caughey, G. E. (2017). What is polypharmacy? A systematic review of definitions. BMC Geriatr, 17(1), 230. DOI: 10.1186/s12877-017-0621-2
- Narayan, S. W., & Nishtala, P. S. (2015). Associations of Potentially Inappropriate Medicine Use with Fall-Related Hospitalisations and Primary Care Visits in Older New Zealanders: A Population-Level Study Using the Updated 2012 Beers Criteria. [journal article]. Drugs - Real World Outcomes, 2(2), 137-141. DOI: 10.1007/s40801-015-0020-y
- Nishtala, P. S., & Salahudeen, M. S. (2015). Temporal Trends in Polypharmacy and Hyperpolypharmacy in Older New Zealanders over a 9-Year Period: 2005-2013. Gerontology, 61(3), 195-202. DOI: 10.1159/000368191
- Park, H. Y., Ryu, H. N., Shim, M. K., Sohn, H. S., & Kwon, J. W. (2016). Prescribed drugs and polypharmacy in healthcare service users in South Korea: an analysis based on National Health Insurance Claims data. Int J Clin Pharmacol Ther, 54(5), 369-377. DOI: 10.5414/cp202484
- Veehof, L., Stewart, R., Haaijer-Ruskamp, F., & Jong, B. M. (2000). The development of polypharmacy. A longitudinal study. Fam Pract, 17(3), 261-267. DOI: 10.1093/fampra/17.3.261
Try the polypharmacy package in your browser
Any scripts or data that you put into this service are public.
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
Embedding an R snippet on your website
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.